These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16710829)

  • 1. [Resistant hypertension and paradox effect in patient with hemodialysis treatment].
    Caglioti A; Bova F; Tozzo C; Fuiano G
    G Ital Nefrol; 2006; 23(2):235-9. PubMed ID: 16710829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive effect of low calcium dialysis.
    Katzir Z; Michlin A; Boaz M; Biro A; Smetana S
    Isr Med Assoc J; 2005 Nov; 7(11):704-7. PubMed ID: 16308992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Control of arterial hypertension by means of a regimen of hemodialysis on alternate days (HDAA or EODD: "Every Other Day Dialysis") versus 2 conventional regiments of 4 and 5 hours per session 3 times a week with 72 hours without sessions during the weekends].
    Lozano A; Benavides B; Quirós P; Jiménez-Moreno J; Figueroa E; Fernández-Marchena D; García-Pérez MA; Fernández-Ruiz E
    Nefrologia; 2006; 26(6):695-702. PubMed ID: 17227247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension in chronic hemodialysis patients: current view on pathophysiology and treatment.
    Grekas D; Bamichas G; Bacharaki D; Goutzaridis N; Kasimatis E; Tourkantonis A
    Clin Nephrol; 2000 Mar; 53(3):164-8. PubMed ID: 10749293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profile of antihypertensive drugs in hypertensive patients on renal replacement therapy (RRT).
    Zazgornik J; Biesenbach G; Forstenlehner M; Stummvoll K
    Clin Nephrol; 1997 Dec; 48(6):337-40. PubMed ID: 9438090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arterial hypertension in patients on long-term haemodialysis].
    Pavlović D; Heinrich B; Germin-Petrović D; Pavlović N
    Lijec Vjesn; 2006; 128(11-12):381-4. PubMed ID: 17212202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients.
    Zheng S; Nath V; Coyne DW
    Am J Nephrol; 2007; 27(5):522-9. PubMed ID: 17700014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistant hypertension: an overview of evaluation and treatment.
    Sarafidis PA; Bakris GL
    J Am Coll Cardiol; 2008 Nov; 52(22):1749-57. PubMed ID: 19022154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure control in haemodialysis patients: an audit.
    Al-Hilali N; Al-Humoud H; Ninan VT; Nampoory MR; Johny KV
    Nephrology (Carlton); 2006 Apr; 11(2):100-4. PubMed ID: 16669969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing dry weight and hypertension in dialysis patients: still a challenge for the nephrologist in 2009?
    Chazot C
    J Nephrol; 2009; 22(5):587-97. PubMed ID: 19809991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypertension in hemodialysis: prevalence and associated factors in Catalonia. The PRESDIAL study].
    Poch E; Martinez X; Rodrigo JA; Tovar JL;
    Nefrologia; 2006; 26(5):564-72. PubMed ID: 17117899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriateness of antihypertensive drug therapy in hemodialysis patients.
    Bishu K; Gricz KM; Chewaka S; Agarwal R
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):820-4. PubMed ID: 17699292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertension in dialysis patients. Italian Guidelines].
    Zoccali C; Panuccio V;
    G Ital Nefrol; 2006; 23(1):49-57. PubMed ID: 16521075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
    Gleim GW; Rubino J; Zhang H; Shahinfar S; Soffer BA; Lyle PA; Littlejohn TW; Feig PU
    Clin Ther; 2006 Oct; 28(10):1639-48. PubMed ID: 17157119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistant hypertension: what to do after trying 'the usual'.
    Kaplan NM
    Geriatrics; 1995 May; 50(5):24-5, 29-30; 33 passim. PubMed ID: 7737525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of antihypertensive drugs in the therapy of patients on regular dialysis treatment.
    Sulková S; Válek A
    Kidney Int Suppl; 1988 Sep; 25():S198-200. PubMed ID: 3184612
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimizing hypertension control in hemodialysis patients: a proposed management strategy.
    Tarrass F; Addou K; Benjelloun M; Zamd M; Medkouri G; Hachim K; Benghanem MG; Ramdani B
    Saudi J Kidney Dis Transpl; 2007 Sep; 18(3):355-60. PubMed ID: 17679745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cluster randomised controlled trial of the effect of a treatment algorithm for hypertension in patients with type 2 diabetes.
    Bebb C; Kendrick D; Coupland C; Madeley R; Stewart J; Brown K; Burden R; Sturrock N
    Br J Gen Pract; 2007 Feb; 57(535):136-43. PubMed ID: 17263930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.